5.84
0.27 (4.85%)
0.27 (4.85%)
Upgrade to Real-Time
Regular Market
Low
0.453
High
6.16
Best deals to access real time data! |
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
Small Cap Basic
Monthly Subscription
for only
|
Big Cap Pro
Monthly Subscription
for only
|
VAT not included
|
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Seelos Therapeutics Inc | SEEL | NASDAQ | Common Stock |
Price Change | Change Percent | Stock Price | Last Traded ![]() |
|
---|---|---|---|---|
0.27 | 4.85% | 5.84 | 11:02:40 |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
5.58 | 5.44 | 5.88 | 5.57 |
Bid Price | Ask Price | Spread | News | |
---|---|---|---|---|
5.84 | 5.85 | 0.01 | - | - |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
5,712 | 1,517,444 | $ 5.71 | $ 8,665,359 | 2,911,830 | 0.453 - 6.16 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
11:02:42 | 51 | $ 5.85 | USD |
Seelos Therapeutics Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 316.33M | 54.40M | 51.18M | $ 375.00k | $ - | -4.47 | -4.50 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | $ - | 0.00% | - | - |
Seelos Therapeutics News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SEEL Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 4.98 | 5.88 | 4.73 | 5.26 | 3,664,032 | 0.86 | 17.27% |
1 Month | 3.6713 | 6.16 | 3.61 | 5.11 | 6,251,599 | 2.17 | 59.07% |
3 Months | 2.27 | 6.16 | 2.00 | 4.50 | 10,389,163 | 3.57 | 157.27% |
6 Months | 0.7831 | 6.16 | 0.722 | 3.99 | 5,847,586 | 5.06 | 645.75% |
1 Year | 0.48 | 6.16 | 0.453 | 3.34 | 3,647,636 | 5.36 | 1,116.67% |
3 Years | 4.02 | 8.00 | 0.4195 | 3.08 | 2,386,493 | 1.82 | 45.27% |
5 Years | 4.02 | 8.00 | 0.4195 | 3.08 | 2,386,493 | 1.82 | 45.27% |
Seelos Therapeutics Description
Seelos Therapeutics Inc is engaged in the pharmaceutical industry. The company's pipeline products include SLS-002 which is intranasal racemic ketamine for patients with suicidality in post-traumatic stress disorder and depressive disorder; SLS-006 which is a small molecule, partial dopamine agonist for Parkinson's Disease; and SLS-005 is Trehalose, a protein stabilizer. Its other pipeline products include SLS-007, SLS-008, SLS-004, SLS-010, and SLS-012. |